Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Turner, T H
Cookson, J C
Wass, J A
Drury, P L
Price, P A
and
Besser, G M
1984.
Psychotic reactions during treatment of pituitary tumours with dopamine agonists..
BMJ,
Vol. 289,
Issue. 6452,
p.
1101.
Abed, R. T.
Clark, J.
Elbadawy, M. H. F.
and
Cliffe, M. J.
1987.
Psychiatric morbidity in acromegaly.
Acta Psychiatrica Scandinavica,
Vol. 75,
Issue. 6,
p.
635.
Sivakumar, Kandiah
and
Williams, Maureen
1991.
Psychiatric aspects of acromegaly – a review and case report.
Irish Journal of Psychological Medicine,
Vol. 8,
Issue. 1,
p.
55.
Brambilla, Francesca
1992.
Psychopathological aspects of neuroendocrine diseases: Possible parallels with the psychoendocrine aspects of normal aging.
Psychoneuroendocrinology,
Vol. 17,
Issue. 4,
p.
283.
Malizia, Andrea L.
and
Bridges, Paul K.
1992.
The management of treatment-resistant affective disorder: clinical perspectives.
Journal of Psychopharmacology,
Vol. 6,
Issue. 2,
p.
145.
Spence, Sean
1995.
The psychopathology of acromegaly.
Irish Journal of Psychological Medicine,
Vol. 12,
Issue. 4,
p.
142.
Peace, K. A.
Orme, S. M.
Thompson, A. R.
Padayatty, S.
Ellis, A. W.
and
Belchetz, P. E.
1997.
Cognitive dysfunction in patients treated for pituitary tumours.
Journal of Clinical and Experimental Neuropsychology,
Vol. 19,
Issue. 1,
p.
1.
Geffken, Gary R.
Ward, Herbert E.
Staab, Jeffrey P.
Carmichael, Stacy L.K.
and
Evans, Dwight L.
1998.
PSYCHIATRIC MORBIDITY IN ENDOCRINE DISORDERS.
Psychiatric Clinics of North America,
Vol. 21,
Issue. 2,
p.
473.
Storch, Eric A.
and
Geffken, Gary R.
2001.
Cambridge Handbook of Psychology, Health and Medicine.
p.
696.
Webb, S. M.
Prieto, L.
Badia, X.
Albareda, M.
Catalá, M.
Gaztambide, S.
Lucas, T.
Páramo, C.
Picó, A.
Lucas, A.
Halperin, I.
Obiols, G.
and
Astorga, R.
2002.
Acromegaly Quality of Life Questionnaire (ACROQOL) a new health‐related quality of life questionnaire for patients with acromegaly: development and psychometric properties.
Clinical Endocrinology,
Vol. 57,
Issue. 2,
p.
251.
Pinto, Denzil
Safeekh, AT
and
Trivedi, Mohit
2005.
Psychotic symptoms in acromegaly.
Indian Journal of Psychiatry,
Vol. 47,
Issue. 1,
p.
58.
Woodhouse, Linda J.
Mukherjee, Annice
Shalet, Stephen M.
and
Ezzat, Shereen
2006.
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults.
Endocrine Reviews,
Vol. 27,
Issue. 3,
p.
287.
Webb, Susan M.
and
Badia, Xavier
2007.
Quality of Life in Growth Hormone Deficiency and Acromegaly.
Endocrinology and Metabolism Clinics of North America,
Vol. 36,
Issue. 1,
p.
221.
Mattoo, Surendra Kumar
Bhansali, Anil Kumar
Gupta, Nitin
Grover, Sandeep
and
Malhotra, Ramma
2008.
Psychosocial morbidity in acromegaly: a study from India.
Endocrine,
Vol. 34,
Issue. 1-3,
p.
17.
Anagnostis, Panagiotis
Efstathiadou, Zoe A.
Charizopoulou, Maria
Selalmatzidou, Despina
Karathanasi, Eleni
Poulasouchidou, Maria
and
Kita, Marina
2014.
Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?.
Endocrine,
Vol. 47,
Issue. 2,
p.
564.
Chin, Sang Ouk
Chung, Choon Hee
Chung, Yoon-Sok
Kim, Byung-Joon
Kim, Hee Young
Kim, In-Ju
Kim, Jung Guk
Kim, Min-Seon
Kim, Seong-Yeon
Lee, Eun Jig
Lee, Ki Young
and
Kim, Sung-Woon
2015.
Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
BMJ Open,
Vol. 5,
Issue. 6,
p.
e006898.
eLetters
No eLetters have been published for this article.